CP-116 Appropriateness of ticagrelor and prasugrel use after the implementation of an antiplatelet p...
CP-116 Appropriateness of ticagrelor and prasugrel use after the implementation of an antiplatelet protocol in acute coronary syndrome
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
BackgroundDue to the inclusion of new antiplatelet treatment in the pharmacotherapeutic guide, the Cardiology Department developed a protocol for management of antiplatelet treatment in Acute Coronary Syndrome (ACS) in May 2013.PurposeTo check whether the new antiplatelet drugs ticagrelor (T) and prasugrel (P) were being used in accordance with a p...
Alternative Titles
Full title
CP-116 Appropriateness of ticagrelor and prasugrel use after the implementation of an antiplatelet protocol in acute coronary syndrome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2552754946
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2552754946
Other Identifiers
ISSN
2047-9956
E-ISSN
2047-9964
DOI
10.1136/ejhpharm-2015-000639.111
